ArticleBioscience reports2021

Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K/Akt pathway.

Yingying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.